Waddell & Reed Financial’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Waddell & Reed Financial’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-297,677	Closed	-$5.5M	–	576
2017 Q3	$5.5M	Hold	297,677	–	–	0.01%	462
2017 Q2	$4.93M	Buy	297,677 +53,700	+22%	+$747K	0.01%	482
2017 Q1	$3.37M	Buy	243,977 +135,000	+124%	+$2.17M	0.01%	503
2016 Q4	$2.07M	Buy	108,977 +46,000	+73%	+$882K	﹤0.01%	545
2016 Q3	$1.4M	Buy	+62,977	New	+$1.18M	﹤0.01%	570
2015 Q3	–	Sell	-87,700	Closed	-$2.27M	–	671
2015 Q2	$2.27M	Hold	87,700	–	–	﹤0.01%	549
2015 Q1	$1.92M	Buy	+87,700	New	+$1.89M	﹤0.01%	535

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Waddell & Reed Financial's ENTL Position: Q4 2017 in Review

Waddell & Reed Financial sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 297,677 shares — an estimated $5.5M sold.

Waddell & Reed Financial first reported a position in ENTL in Q1 2015 and held it in 7 quarters. The position peaked at $5.5M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

Waddell & Reed Financial reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Waddell & Reed Financial sold 297,677 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $5.5M.
Waddell & Reed Financial first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Waddell & Reed Financial's Entellus Medical, Inc. Common Stock position peaked at $5.5M in Q3 2017.
83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Waddell & Reed Financial's 13F filing for Q4 2017, filed 14 Feb 2018.